Clincosm LogoSign in Get a demo

Hepatitis C

Showing 26 - 50 of 894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid-use Disorder, HIV, Tuberculosis Trial in Bishkek, Chisinau, Kyiv (SBIRT)

Recruiting
  • Opioid-use Disorder
  • +6 more
  • SBIRT
  • Bishkek, Kyrgyzstan
  • +2 more
Nov 9, 2022

Human Immunodeficiency Virus, Hepatitis C, Alcohol Abuse Trial in New York, Saint Petersburg (Computer-based alcohol reduction

Completed
  • Human Immunodeficiency Virus
  • +2 more
  • Computer-based alcohol reduction intervention
  • +2 more
  • New York, New York
  • +1 more
Oct 31, 2022

Hepatitis C, HCV Trial (Telehealth in Parole/Probation Office)

Recruiting
  • Hepatitis C
  • HCV
  • Telehealth in Parole/Probation Office
  • Lexington, Kentucky
    University of Kentucky
Oct 11, 2022

Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

Active, not recruiting
  • Liver Transplant
  • Hepatitis C
  • Pittsburgh, Pennsylvania
    UPMC
Oct 6, 2022

HCV-TARGET- Hepatitis C Therapeutic Registry and Research

Active, not recruiting
  • Hepatitis C
    • Phoenix, Arizona
    • +59 more
    Oct 5, 2022

    Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))

    Recruiting
    • Hepatitis C
    • +2 more
    • Sofosbuvir/velpatasvir (Epclusa®)
    • Hazard, Kentucky
      ARH Medical Mall
    Sep 25, 2022

    Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)

    Recruiting
    • Hepatitis C
    • HCV RNA Point of Care
    • +2 more
    • Sydney, New South Wales, Australia
      NUAA NSP
    Aug 19, 2022

    Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick

    Recruiting
    • Hepatitis C
    • OraQuick HCV Antibody test (OraSure Technologies, Inc)
    • +2 more
    • Clayton South, Victoria, Australia
    • +5 more
    Aug 16, 2022

    Blood From Healthy Patients, Benign Disease and Cancer

    Recruiting
    • Cancer
    • +6 more
    • Multi-analyte Blood Test
    • Redondo Beach, California
    • +6 more
    Aug 16, 2022

    Ablation of Hepatocellular Carcinoma: a Nationwide Study

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Ablation therapy
    • Copenhagen, Denmark
      Rigshospitalet
    Aug 10, 2022

    IV Drug Usage, HIV, Hepatitis C Trial in Miami, Tampa (Tele-Harm Reduction, off-site linkage)

    Not yet recruiting
    • IV Drug Usage
    • +2 more
    • Tele-Harm Reduction
    • off-site linkage
    • Miami, Florida
    • +1 more
    Aug 9, 2022

    Health and Migration Trajectories of Housekeepers in Bamako

    Not yet recruiting
    • HIV Infections
    • +5 more
    • Community-based healthcare offer provided by an the ARCAD Santé PLUS NGO and integrated into the activities of the ADDAD NGO
    • Bamako, Niamakoro, Sièbougouni, Rue 173, Porte 146, Mali
      ADDAD
    Jul 21, 2022

    Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

    Not yet recruiting
    • Hepatitis C
    • Cirrhosis
    • (no location specified)
    Jul 20, 2022

    Hepatitis C, Opioid Use Disorder, IV Drug Usage Trial in Keene, Brattleboro (Mobile Tele-HCV Care, Enhanced Usual Care)

    Recruiting
    • Hepatitis C
    • +2 more
    • Mobile Tele-HCV Care
    • Enhanced Usual Care
    • Keene, New Hampshire
    • +1 more
    Jul 18, 2022

    Hepatitis C, Smoking Cessation Trial in Greenville (Cognitive Behavioral Counseling)

    Completed
    • Hepatitis C
    • Smoking Cessation
    • Cognitive Behavioral Counseling
    • Greenville, South Carolina
      Prisma Health Internal Medicine Clinic
    Jul 18, 2022

    Hepatitis C Trial (Zinc Supplement)

    Not yet recruiting
    • Hepatitis C
    • Zinc Supplement
    • (no location specified)
    Jul 16, 2022

    Plasma MicroRNA for Prediction of Hepatocellular Carcinoma

    Completed
    • Hepatitis C
    • Blood Sampling
    • Banhā, El- Qalyobia, Egypt
      Benha university
    Jul 5, 2022

    Utilization of MAsS in Patients Undergoing LT for HCC

    Recruiting
    • NAFLD
    • +5 more
      • New York, New York
        Columbia University Irving Medical Center
      Jun 29, 2022

      Zepatier in Patients With Substance Use

      Active, not recruiting
      • Hepatitis C
      • +3 more
      • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
      • Chicago, Illinois
        University of Illinois at Chicago
      Jun 28, 2022

      Hepatitis C Trial in Blain, Bouguenais, Nantes (Evaluation of the prevalence of HCV, HBV and HIV viral infections)

      Recruiting
      • Hepatitis C
      • Evaluation of the prevalence of HCV, HBV and HIV viral infections
      • Blain, France
      • +2 more
      Jun 8, 2022

      Hepatitis C Trial in Victoria (Hepatitis C Point of Care Testing and Treatment)

      Recruiting
      • Hepatitis C
      • Hepatitis C Point of Care Testing and Treatment
      • Victoria, British Columbia, Canada
        Cool Aid Community Health Centre
      Jun 6, 2022

      Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury Trial in United States (Cannabis, Medical, RYAH-Medtech Inhaler)

      Recruiting
      • Chronic Pain
      • +32 more
      • Cannabis, Medical
      • RYAH-Medtech Inhaler
      • Boca Raton, Florida
      • +16 more
      May 29, 2022

      Surveillance of HCV in Uremics and Linking to Medical Care

      Completed
      • Hepatitis C
      • blood test, noninvasive test for liver fibrosis
      • Kaohsiung, Taiwan
        Kaohsiung Medical University Hospital
      May 26, 2022

      Hepatitis B, Hepatitis C, AIDS Trial in Rouen (Blood collection using Dried Blood Spot)

      Not yet recruiting
      • Hepatitis B
      • +2 more
      • Blood collection using Dried Blood Spot
      • Rouen, France
        CSAPA la Boussole
      May 20, 2022

      Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))

      Completed
      • Hepatitis C
      • Hepatitis C Virus Infection, Response to Therapy of
      • glecaprevir/pibrentasvir (GLE/PIB)
      • San Diego, California
        University of California San Diego
      May 23, 2022